ArticleActa parasitologica2026
Effects of Exosomes Derived from Hydatid Cyst Stem Cells on Human Hepatocytes.
Article in Acta parasitologica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeHydatid cyst disease is a zoonotic infection that predominantly affects the liver and can lead to severe hepatic complications. Exosomes are important mediators of intercellular signaling and are capable of transferring bioactive molecules to target cells. This study aimed to investigate the biological effects of exosomes derived from hydatid cyst stem cells on human hepatocytes to better understand parasite-associated hepatic alterations.
methodsIn this in vitro experimental study, stem cells were isolated from the germinal layer of hydatid cysts and cultured. Cell identity was confirmed by flow cytometry. Exosomes were isolated using sequential filtration and characterized by dynamic light scattering (DLS). Human hepatocytes were divided into control and exosome-treated groups. Cell viability was assessed using the MTT assay. Gene expression levels of apoptosis-related markers (Bax, Bcl-2, Caspase-3, and Caspase-7) were determined by qPCR, and protein levels were quantified using ELISA.
resultsExosomes derived from hydatid cyst stem cells significantly reduced the viability of human hepatocytes (P < 0.0001). Moreover, exosome exposure was associated with increased expression and protein levels of pro-apoptotic markers, including Bax, Caspase-3, and Caspase-7, along with decreased expression of the anti-apoptotic marker Bcl-2.
conclusionHydatid cyst stem cell-derived exosomes promote apoptotic changes in human hepatocytes in vitro. These findings provide preliminary evidence suggesting a potential role for parasite-derived extracellular vesicles in hepatic cellular alterations observed during hydatid disease.
Indexed as
Identifiers
42440022What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.